Form 4: Ameriprise CEO Cracchiolo Reports Stock Transactions

Sentiment:

Insider Transaction Report


Ameriprise Financial CEO James M. Cracchiolo reported recent transactions involving company common stock and the acquisition of new employee stock options.

Summary

  • James M. Cracchiolo, Chairman and CEO of Ameriprise Financial Inc. (AMP), reported changes in his beneficial ownership of company securities.
  • On January 31, 2026, Cracchiolo disposed of 1,729 shares of common stock at a price of $527.19 per share.
  • On February 2, 2026, he acquired 11,988 shares of common stock at a price of $0, likely through a grant or vesting event.
  • Following these transactions, his direct beneficial ownership of common stock stands at 156,446 shares.
  • Additionally, he holds an estimated 1,724.75 shares indirectly through a 401(k) plan as of February 2, 2026.
  • On February 2, 2026, Cracchiolo was granted 33,299 employee stock options with an exercise price of $532.18.
  • These options vest in three equal annual installments, starting one year from the grant date, and expire on February 3, 2036.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as slightly positive due to the significant grant of employee stock options, which aligns the CEO's long-term incentives with shareholder value, despite a routine disposition of shares.

Positives

  • Acquisition of 11,988 shares of common stock at $0, indicating a grant or vesting event.
  • Grant of 33,299 employee stock options, aligning management's interests with long-term shareholder value.
  • The employee stock options have a 10-year expiration date (February 3, 2036), providing a long-term incentive for the CEO.

Negatives

  • Disposition of 1,729 shares of common stock at $527.19 per share, which could be for tax withholding purposes related to equity awards.

Risks

  • The value of the newly acquired employee stock options is subject to future market price fluctuations of Ameriprise Financial Inc. common stock.
  • The vesting schedule for the options means the full benefit is contingent on continued employment and company performance over three years.

Future Outlook

The employee stock options granted on February 2, 2026, will vest in three equal annual installments over the next three years, with one-third vesting after one year, one-third after two years, and the final one-third after three years from the grant date. The options expire on February 3, 2036.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insiders of publicly traded companies, detailing changes in their beneficial ownership. These transactions, particularly option grants and tax-related dispositions, are common practices for executive compensation and personal financial management within the financial services industry.

Stakeholder Impact

  • Shareholders: The grant of stock options to the CEO aligns management's long-term interests with shareholder value, potentially encouraging decisions that enhance stock price.
  • Management: The CEO receives significant long-term incentives tied to company performance through the stock option grant.

Next Steps

  • Vesting of employee stock options in three annual installments, starting one year from February 2, 2026.

Key Dates

DateDescription
01/31/2026Date of disposition of 1,729 shares of common stock by James M. Cracchiolo.
02/02/2026Date of acquisition of 11,988 shares of common stock and grant of 33,299 employee stock options to James M. Cracchiolo. Also, the date for the estimated number of shares held in the 401(k) plan.
02/03/2026Signature date of the Form 4 filing.
02/03/2036Expiration date of the employee stock options granted on February 2, 2026.

Recommendation

hold

Routine insider transactions, including tax-related sales and option grants, do not typically signal a change in company fundamentals or warrant a strong directional recommendation. This filing primarily reflects standard executive compensation and personal financial management.

Keywords

Ameriprise Financial, AMP, Form 4, Insider Transaction, Stock Options, CEO, Beneficial Ownership, Equity Grant

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.